“COVID-19 has undoubtedly changed all of our lives and brought much of the world to a standstill,” says Sharon Chan, Head, JLABS @ Shanghai, Johnson & Johnson, “but it has also brought many opportunities with it, especially across digital healthcare.”
Digital transformation has significantly accelerated as a result of the pandemic, especially in the healthcare arena. There has been a move towards tele-medicine, online medical service, and personalized diagnosis and treatment, and experts at JOhn & Johnson say they expect consultations, diagnosis, and monitoring to become more convenient and quicker through digital technology. As a result, there has never been a better time for forward-thinking start-ups to make a difference in healthcare by developing and delivering innovative tech solutions.
Johnson & Johnson Innovation – JLABS @ Shanghai provides an important platform for these start-ups to thrive by offering the resources they need on their journey to bringing new solutions to patients.
On September 17 at the AmCham China Technology and Innovation Summit, Johnson & Johnson's Sharon Chan will lead a discussion with some of the leading start-up CEOs in Johnson & Johnson’s global network of JLABS resident companies to hear more about how open innovation is shaping the future of healthcare in a post-pandemic world. Joining Chan on the panel are Hailiang Shi, CEO & Co-Founder of Live2Life Health Tech; Nawal Roy, Founder & CEO of Holmusk; and Alex Zhavoronkov, CEO of Insilico Medicine.